Abstract
Introduction: One of the main causes of illness and death in communities is cardiovascular disease (CVD). Inflammation and oxidative stress are key components in the pathophysiology of CVD. It has been demonstrated that selenium lowers inflammation and oxidative stress. The purpose of this study is to do biochemical assessment of selenium’s cardiovascular protective effects in a lipopolysaccharide (LPS)-Induced damage in rats.
Methods: LPS+Selenium (100 µg/kg), LPS (1 mg/kg), LPS+Selenium (200 µg/kg), and Vehicle (instead of both selenium and LPS) were given to the four groups of rats. The rats were sacrificed after 14 days, and the serum, heart, and aorta were examined for the presence of malondialdehyde (MDA), thiol, catalase (CAT), and superoxide dismutase (SOD). Interleukin 6 (IL-6) was also assessed in the tissues of the heart and aorta as an indicator of inflammation.
Results: LPS administration raised aortic and cardiac IL-6 levels (P<0.001). In the heart, aorta, and serum, it also raised MDA (P<0.001) and lowered thiol (P<0.001), CAT (P<0.01-P<0.001), and SOD (P<0.001). On the other hand, selenium therapy markedly raised thiol, CAT, and SOD levels (P<0.01-P<0.001) and lowered MDA levels (P<0.05-P<0.001). Furthermore, following selenium delivery, a decrease in the inflammatory marker IL-6 was noted (P<0.01-P<0.001).
Conclusion: This study showed that selenium protected the heart, aorta, and serum from oxidative stress brought on by LPS. Additionally, it reduced aortic and cardiac inflammation. These results imply that selenium’s anti-inflammatory and antioxidant properties may help prevent or lower the morbidity and mortality of CVD.